NRX Pharmaceuticals Q4 EPS $0.20 Up From $(0.77) YoY, Sales $983.000K

NRX Pharmaceuticals reported a Q4 earnings per share (EPS) of $0.20, a significant improvement from a loss of $(0.77) per share in the same quarter last year, representing a 125.97% increase. The company's sales for the quarter reached $983,000.